2m 2m 2m 2m 2m 2m 2m
- N/AMarket Cap
- -10.75%1-Year Change
- Household & Personal ProductsIndustry
Reckit BK Sp ADR (RBGLY)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 64
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
The global laundry detergents market is projected to grow from USD 79.2 billion in 2025 to USD 131.49 billion by 2035, with a CAGR of 5.20%. Growth is driven by increasing demand for liquid detergents and single-dose pods, premiumization of fabric care products, and expansion in e-commerce distribution. The U.S. market is expected to reach USD 23.24 billion by 2035, while Europe hits USD 33.54 billion, with North America as the fastest-growing region.
05/30/2026, 9:30 AM • GlobeNewswire
The global infant nutrition market is shifting from volume-based to value-driven growth, projected to reach $162.08 billion by 2035 at a 10.26% CAGR. Despite declining birth rates, premium formulations and specialized nutrition products are driving growth. Major players are investing heavily in domestic manufacturing, regulatory compliance, and product innovation, while safety recalls and consolidation reshape the competitive landscape.
02/02/2026, 10:30 AM • GlobeNewswire
United States Air Fresheners Market Report 2025: Consumer Trends & Forecasts to 2033
The US air fresheners market is projected to grow from $2.71 billion in 2024 to $3.86 billion by 2033, driven by consumer preferences for home and car fragrances, with a 4.02% CAGR. Market growth is fueled by increasing demand for personalized, hygienic fragrance solutions across residential, automotive, and commercial sectors.
11/26/2025, 4:54 AM • GlobeNewswire
The global contraceptive devices market is projected to grow from $20 billion in 2024 to $33 billion by 2032, driven by increased awareness, technological innovations, and changing demographic trends.
11/17/2025, 1:00 PM • GlobeNewswire
The global mosquito repellent market is projected to grow from $5.3 billion in 2024 to $8.1 billion by 2033, driven by increasing awareness of mosquito-borne diseases, travel expansion, and consumer preference for natural ingredients like citronella.
08/19/2025, 6:56 AM • GlobeNewswire
Reckitt Benckiser faces a class action lawsuit alleging misleading statements about health risks associated with its Enfamil infant formula, particularly for preterm infants. Two jury verdicts totaling $555 million have highlighted potential negligence in warning about Necrotizing Enterocolitis (NEC) risks.
08/04/2025, 6:00 PM • GlobeNewswire
Rosen Law Firm reminds investors of an important August 4, 2025 deadline for a securities class action lawsuit against Reckitt Benckiser Group PLC, alleging the company failed to disclose risks related to infant formula and potential legal liabilities.
08/03/2025, 11:03 AM • GlobeNewswire
Rosen Law Firm is alerting Reckitt Benckiser Group PLC investors about a securities class action lawsuit regarding potential misleading statements about risks associated with their Enfamil infant formula.
08/03/2025, 11:03 AM • GlobeNewswire
A class action lawsuit has been filed against Reckitt Benckiser Group for allegedly misleading investors about health risks associated with their infant formula, with over 500 products liability lawsuits claiming increased necrotizing enterocolitis risk for premature infants.
08/02/2025, 10:21 AM • GlobeNewswire
The Gross Law Firm is notifying shareholders of Reckitt Benckiser Group plc about a potential class action lawsuit regarding allegations of misleading statements about health risks associated with their Enfamil infant formula.
07/31/2025, 8:45 AM • Benzinga
A class action lawsuit has been filed against Reckitt Benckiser Group PLC alleging false statements about health risks associated with their Enfamil infant formula, specifically concerning necrotizing enterocolitis (NEC) in preterm infants.
07/30/2025, 4:00 PM • GlobeNewswire
Law firm alerts investors about potential securities class action lawsuit against Reckitt Benckiser for allegedly failing to disclose material information about health risks associated with Enfamil infant formula.
07/29/2025, 10:30 PM • GlobeNewswire
Reckitt Benckiser Group plc faces a class action lawsuit alleging securities fraud related to potential health risks associated with their Enfamil infant formula, with investors having until August 4, 2025 to participate in potential legal recovery.
07/29/2025, 8:45 AM • Benzinga
A class action lawsuit has been filed against Reckitt Benckiser Group for allegedly misleading investors about health risks associated with their infant formula, with over 500 products liability lawsuits claiming increased necrotizing enterocolitis risk for premature infants.
07/28/2025, 7:09 PM • GlobeNewswire
Reckitt Benckiser faces a class action lawsuit alleging failure to warn consumers about health risks associated with Enfamil infant formula, potentially causing Necrotizing Enterocolitis (NEC) in preterm infants.
07/28/2025, 4:44 PM • GlobeNewswire
Peers
Statistics
MoreInformation as of 06/22/2026
Company Profile
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, Delsym, Cepacol, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names; vitamins, minerals, and supplements under MegaRed, Airborne, Digestive-Advantage, Movefree, and neuriva names; stain removal under Vanish brand name; and disinfectant products under the Finish, Harpic, and Lysol brands. In addition, the company offers nutritious complementary foods and milk formulas for infant and young children under the Enfamil and Nutramigen brands. Reckitt Benckiser Group plc was founded in 1819 and is headquartered in Slough, the United Kingdom.
Key Executives
- Kristoffer Loe Licht
- Shannon Sue Eisenhardt
- Nicholas James Ashworth
- Ranjay Radhakrishnan
- Angela Naef
Current Ownership Distribution
- Other2.9B (92.16%)
- Mutual Funds191.2M (6.02%)
- Institutions57.6M (1.81%)
- Insiders0 (0.00%)